Precision Medicine Trials in Retinal Degenerations.

Annual Review of Vision Science
Sarah R LeviStephen H Tsang


The beginning of the twenty-first century was marked by the innovative use of pharmacochemical interventions, which have since expanded to include gene-based molecular therapies. For years, treatment has focused on tackling the pathophysiology of monogenic orphan diseases, and one of the first applications of these novel genome editing technologies was the treatment of rare inherited retinal dystrophies. In this review, we present recent, ongoing, and future gene therapy-based treatment trials for choroideremia, X-linked retinitis pigmentosa, Stargardt disease, and age-related macular degeneration. As these trials pave the way toward halting the progression of such devastating diseases, we will begin to see the exciting development of newer, cutting-edge strategies including base editing and prime editing, ushering in a new era of precision medicine.


Oct 1, 1992·Nature Genetics·T Friedmann
Nov 27, 1980·The New England Journal of Medicine·W F Anderson, J C Fletcher
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Jun 2, 2004·The Journal of Gene Medicine·Michael L EdelsteinRichard M Edelstein
Aug 29, 2006·Investigative Ophthalmology & Visual Science·Samuel G JacobsonIan M MacDonald
Feb 28, 2007·Investigative Ophthalmology & Visual Science·Michael A SandbergEliot L Berson
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Apr 29, 2008·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Jul 26, 2008·Progress in Retinal and Eye Research·J S PennM E Hartnett
Aug 20, 2010·Investigative Ophthalmology & Visual Science·Donald C HoodDavid G Birch
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jul 17, 2012·Neuron·Jayakrishna Ambati, Benjamin J Fowler
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giedrius GasiunasVirginijus Siksnys
Oct 11, 2012·Frontiers in Immunology·Inbal BenharMichal Schwartz
Dec 19, 2013·Translational Vision Science & Technology·Rithambara RamachandranDonald C Hood
Apr 16, 2014·Developments in Ophthalmology·Katherine J WertStephen H Tsang
Oct 25, 2014·Investigative Ophthalmology & Visual Science·Cindy X CaiDonald C Hood
Jan 24, 2015·Expert Opinion on Biological Therapy·Andrew ZhengStephen H Tsang
Apr 28, 2016·The New England Journal of Medicine·Thomas L EdwardsRobert E MacLaren
Oct 30, 2016·The British Journal of Ophthalmology·Preena TannaMichel Michaelides
Oct 7, 2016·Human Gene Therapy·Peter A CampochiaroKyriacos A Mitrophanous
Nov 8, 2016·Investigative Ophthalmology & Visual Science·Matthew P SimunovicRobert E MacLaren
Apr 2, 2017·Progress in Retinal and Eye Research·Suzanne BroadgateStephanie Halford
May 5, 2017·Proceedings of the National Academy of Sciences of the United States of America·Susanne F KochStephen H Tsang
May 14, 2017·American Journal of Ophthalmology·Amir H HaririUNKNOWN Natural History of the Progression of Choroideremia (NIGHT) Study Group
May 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·M Dominik FischerRobert E MacLaren
Jun 26, 2018·American Journal of Ophthalmology·Ioannis S DimopoulosIan M MacDonald
Jul 24, 2018·Translational Vision Science & Technology·Jacque L DuncanUNKNOWN and the Foundation Fighting Blindness Scientific Advisory Board
Sep 22, 2018·American Journal of Ophthalmology·Byron L LamWilliam J Feuer
Nov 2, 2018·Human Gene Therapy·Michelle E McClementsRobert E MacLaren
Dec 12, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ruslan GrishaninMehdi Gasmi
Apr 2, 2019·Investigative Ophthalmology & Visual Science·Marc Figueras-RocaAlfredo Adán
Aug 14, 2019·The Journal of Clinical Investigation·Kun DingPeter A Campochiaro

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.